pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Hepatology · news · pharmadog
← back to Hepatology
News · Hepatology
262
stories
Sep 29, 26
Highlight Therapeutics illuminates positive ph. 2 topline data in high-risk skin cancer
fiercebiotech
Sep 28, 26
Mirum posts phase 3 hepatitis win for ‘commercially differentiated’ challenger to Gilead, Vir
fiercebiotech
Sep 25, 26
How NIH’s Nicole Kleinstreuer is working to reduce animal testing while avoiding a ‘backlash’
fiercebiotech
Sep 25, 26
Opinion: The ‘died with’ vs. ‘died of’ measles discussion misses something very important
stat
Sep 25, 26
RNAi drug specialist ADARx raises $446M IPO
biopharma dive
Sep 24, 26
Pioneer of China NewCo model sued in US over trade secret misuse, double-dealing
fiercebiotech
Sep 24, 26
Chutes & Ladders—Travere chief makes way for former Amicus CEO
fiercebiotech
Sep 24, 26
Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs
fiercebiotech
Sep 24, 26
Grail survives adcomm vote as it awaits FDA decision for cancer blood test
fiercebiotech
Sep 23, 26
Roche, Ionis RNA drug scores in kidney disease study
biopharma dive
Sep 22, 26
Compass vows to press on with FDA application despite new trial request
biospace
Sep 22, 26
Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030
biospace
Sep 22, 26
Novo’s workforce reduction climbs to 13,000 to fuel R&D work
biospace
Sep 22, 26
Siemens Healthineers and Novo team up on fatty liver disease awareness, testing
fiercebiotech
Sep 22, 26
Opinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?
stat
Sep 21, 26
Novo’s plan to hit $23B in revenue by 2035 leaves investors wanting
biospace
Sep 21, 26
Skeptical about modern medicine? I know the feeling — and want to listen
stat
Sep 18, 26
Electra amasses $350M in biotech’s latest big IPO
biopharma dive
Sep 17, 26
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
fda press
Sep 17, 26
Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol
fiercebiotech
Sep 16, 26
Sling catches $123M series C for thyroid eye disease pill
biospace
Sep 14, 26
After a brief storm of political headwinds, mRNA is back with strong momentum
biospace
Sep 11, 26
Boycott launched against American Diabetes Association includes journal
stat
Sep 11, 26
FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer
fiercebiotech
Sep 11, 26
STAT+: An AI tool aims to catch harder-to-detect heart attacks in EKGs
stat
Sep 10, 26
Platinum-based chemotherapy in childhood causes mutations that age the liver
stat
Sep 10, 26
A booming business on Wall Street would love more biotechs to quietly die
biopharma dive
Sep 10, 26
Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters
fiercebiotech
Sep 9, 26
CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’
fiercebiotech
Sep 8, 26
Moonwalk reloads with $70M and new RNAi prospects for obesity
biopharma dive
← prev
page 4 of 9
next →